STELAX INDUSTRIES LTD
10-Q, 2000-11-21
PROFESSIONAL & COMMERCIAL EQUIPMENT & SUPPLIES
Previous: CABLETRON SYSTEMS INC, S-4/A, EX-23.4, 2000-11-21
Next: ALLION HEALTHCARE INC, DEF 14A, 2000-11-21



                     U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                    Form 10-Q


(Mark One)

    [X]  QUARTERLY  REPORT  UNDER  SECTION  13 OR 15(d)  OF THE  SECURITIES
         EXCHANGE ACT OF 1934
                For the quarterly period ended September 30, 2000

    [ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
       For the transition period from __________________ to ______________

Commission file number: 1-14219

                             Stelax Industries Ltd.
-------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)

        British  Columbia                             None
---------------------------------------   -------------------------------------
(State  or  other   jurisdiction  of      (IRS Employer Identification No.)
incorporation  or organization)

  4004 Beltline Road, Suite 107, Dallas TX                   75244
-------------------------------------------------------------------------------
 (Address of principal executive offices)                 (Zip Code)

                                 (972) 233-6041
-------------------------------------------------------------------------------
                         (Registrant's telephone number)

-------------------------------------------------------------------------------
(Former  name,  former  address and former  fiscal year,  if changed  since last
report)
         Check whether the issuer (1) filed all reports  required to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days. Yes X No ____

                      APPLICABLE ONLY TO CORPORATE ISSUERS

         State the number of shares  outstanding of each of the issuer's classes
of common equity, as of November 1, 2000: 37,521,442











<PAGE>


                         PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

                              Stelax Industries Ltd

                           CONSOLIDATED BALANCE SHEETS
                      (Presented in United States dollars)

                                     ASSETS
<TABLE>
<CAPTION>
                                                                   September 30,          March 31,
                                                                        2000              2000
                                                                      Unaudited
                                                                     -----------      ----------
CURRENT ASSETS:
<S>                                                                  <C>             <C>
       Cash and cash equivalents                                     $ 2,811,468     $    44,660
       Note Receivable                                                   141,480         141,480
       Inventory-Raw materials                                            61,111          10,283
         Work in process                                                   8,591          26,315
         Finished goods                                                  108,588         118,687
       Accounts Receivable-Trade, net (allowance for
         doubtful accounts at Sept. 30 and March 31,
         2000, $0 and $0, respectively)                                   89,349          62,447
       Prepaids and other current assets                                 269,674          81,529
                                                                      ----------      ----------

       Total Current Assets                                            3,490,261         485,401

PROPERTY & EQUIPMENT-AT COST:
       Plant & Machinery                                               9,338,619       9,290,878
       Building                                                          848,843         848,843
       Land                                                              270,136         270,136
                                                                      ----------      ----------
                                                                      10,457,598      10,409,857
       Accumulated Depreciation                                       (1,974,991)     (1,753,567)
                                                                      ----------      ----------

       Total Property & Equipment                                      8,482,607       8,656,290

INTANGIBLE ASSETS (accumulated amortization of
         $243,677 and $218,343 at Sept. 30 and
         March 31, 2000, respectively)                                   577,176         556,685

OTHER ASSETS                                                              48,503          29,450
                                                                      ----------      ----------

TOTAL ASSETS                                                        $ 12,598,547     $ 9,727,826
                                                                     ===========      ==========
</TABLE>



                                   (Continued)
                       See notes to financial statements.



<PAGE>


                              Stelax Industries Ltd

                           CONSOLIDATED BALANCE SHEETS
                      (Presented in United States dollars)
                                   (Continued)

                      LIABILITIES AND STOCKHOLDERS' EQUITY
<TABLE>
<CAPTION>
                                                      September 30,       March 31,
                                                      2000                  2000
                                                      Unaudited
                                                      -----------         ----------

CURRENT LIABILITIES:
<S>                                                   <C>                 <C>
       Accounts payable                               $    910,892        $ 1,546,615
       Payable to related parties                          932,420          1,265,068
       Note payable--short term                          1,250,000                  -
                                                        ----------         ----------

       Total Current Liabilities                         3,093,312          2,811,683

NOTE PAYABLE--LONG TERM                                  3,670,833                  -

STOCKHOLDERS' EQUITY:
      Common stock - 50,000,000 shares
         authorized, no stated par value;
         issued and outstanding 37,521,442
         shares at Sept. 30 and March 31,
        2000, respectively.                             23,686,222         23,686,222
       Cumulative translation adjustments                  260,248            195,679
      Accumulated deficit                              (18,112,068)       (16,965,758)
                                                       ------------        ----------

       Total Stockholders' Equity                     $  5,834,402        $ 6,916,143
                                                       -----------         ----------

TOTAL LIABILITIES AND
       STOCKHOLDERS' EQUITY                           $ 12,598,547        $ 9,727,826
                                                      ============       ============
</TABLE>



                       See notes to financial statements.





<PAGE>



                              Stelax Industries Ltd

                      CONSOLIDATED STATEMENTS OF OPERATIONS
                      (Presented in United States dollars)
                                    Unaudited

<TABLE>
<CAPTION>

                                                                 Three Months Ended                     Six Months Ended
                                                          ------------------------------------   ----------------------------------
                                                          September 30,       September 30,       September 30,      September 30,
                                                             2000               1999                2000                1999
                                                          ---------------     -------------       -------------      -------------
<S>                                                       <C>                 <C>                 <C>                <C>
Sales                                                     $        55,824     $      49,854       $     188,993      $      93,443
Cost of sales                                                      85,274           209,865             351,803            358,238
                                                           --------------      ------------        ------------         ----------

Gross loss                                                        (29,450)         (160,011)           (162,810)          (264,795)

Selling, general and administrative expenses
  (including depreciation and amortization of
  $265,927 and $276,975 for the six months
  ending Sept. 30, 2000 and 1999, respectively)                   502,737           368,162             816,376            716,018
                                                           --------------      ------------        ------------         -----------


Loss from operations                                             (532,187)         (528,173)           (979,186)          (980,813)

Other income (expense):
  Interest income                                                  18,560                 -              18,560                  -
  Interest expense                                               (163,687)          (19,316)           (185,684)           (27,626)
                                                           --------------      ------------        ------------         -----------


Net loss                                                  $      (677,314)    $    (547,489)      $  (1,146,310)       $(1,008,439)
                                                           ==============      ============        ============         ===========



Weighted average shares of common stock                        37,521,442        35,989,691          37,521,442         35,976,781
                                                           ==============      ============        ============         ===========



Net loss per share                                        $        (0.02)     $      (0.02)       $      (0.03)        $    (0.03)
                                                           ==============      ============        ============         ===========
</TABLE>




          See notes to financial statements.


<PAGE>



                              Stelax Industries Ltd
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                      (Presented in United States dollars)
                                    Unaudited
<TABLE>
<CAPTION>
                                                                             Six Months Ended
                                                                     ------------------------------------
                                                                      September 30,        September 30,
                                                                         2000                   1999
                                                                     ----------------     ---------------
OPERATING ACTIVITIES
<S>                                                                  <C>                   <C>
  Net loss                                                           $   (1,146,310)       $   (1,008,439)
  Adjustments to reconcile net loss
  to net cash provided by operating
  activities:
       Depreciation & amortization                                          265,927               276,975
       Foreign currency transaction gain (loss)                              64,569                (4,368)
      Changes in operating assets and liabilities:
         Decrease (increase) in receivables                                 (26,902)              (37,453)
          Decrease (increase) in inventory & other assets                  (249,372)               93,110
         Increase (decrease) in accounts
             payable & accrued interest                                    (968,370)              395,323
                                                                      -------------         -------------

Net cash (used) provided by operating activities                         (2,060,458)             (284,852)

INVESTING ACTIVITIES
  Purchase of property, equipment & intangibles                             (93,567)              (46,272)
                                                                      -------------         -------------

Net cash used by investing activities                                       (93,567)              (46,272)
FINANCING ACTIVITIES
  Convertible note payable issue                                                  -               318,914
  Note payable issue                                                      4,920,833                    -
                                                                      -------------         -------------
                                                                          4,920,833               318,914

Increase (decrease) in cash and cash
  equivalents                                                             2,766,808               (12,210)

Cash & cash equivalents at beginning
  of period                                                                  44,660                42,973
                                                                      -------------         -------------

Cash & cash equivalents at end of period                             $    2,811,468        $       30,763
                                                                      =============         =============

  Interest paid                                                      $        4,955        $        7,400
                                                                      =============         =============

  Income taxes paid                                                  $            -        $            -
                                                                      ==============        =============
</TABLE>

               See notes to financial statements.


<PAGE>


                             STELAX INDUSTRIES LTD.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                      (Presented in United States Dollars)
                                    Unaudited

(1)  INTERIM FINANCIAL STATEMENTS

In the opinion of  management,  the  interim  financial  statements  reflect all
adjustments necessary to a fair statement of the results for the interim periods
presented.  The  results  for the six months  ended  September  30, 2000 are not
necessarily  indicative  of results to be expected  for the entire  year.  These
financial statements,  notes and analyses should be read in conjunction with the
Company's annual financials for the fiscal year ended March 31, 2000.

(2)  LOSS PER SHARE

Loss per share  was based on the  weighted  average  number of common  shares of
37,521,442  and  35,976,781  outstanding  during  the  six  month  period  ended
September 30, 2000 and 1999, respectively.

(3)  INCOME TAXES

The Company has net operating loss carry forwards of approximately  $420,000 for
Canada and $6,200,000 for the U.K.

(4)  RELATED PARTY TRANSACTIONS

As of September 30, 2000, funds are owed by the Company totaling $885,153 to the
President of the Company and his affiliates. Of this amount, $692,904 represents
draws and accrued interest upon the line of credit  established by the President
on behalf of the Company.  As of March 31, 2000,  the Company owed the President
of  $1,049,172.  The president and a director of the subsidiary are owed $47,267
and $215,896 as of September 30, 2000 and March 31, 2000, respectively.

(5)  FINANCING

On June 30,  2000,  the  Company  closed on a financing  agreement  with Bank of
America.  The  loan  was  funded  in  early  July.  As  part  of  the  financing
arrangement,  Bank of America  received  160,000 options on the Company's common
stock.









<PAGE>



Forward-Looking Information

The Management's  Discussion and Analysis of Financial  Condition and Results of
Operations  and  other  sections  of  the  Form  10-Q  contain   forward-looking
information.  The forward-looking  information  involves risks and uncertainties
that are based on current  expectations,  estimates,  and projections  about the
Company's  business,  management's  beliefs and assumptions  made by management.
Words such as "expects", "anticipates", "intends", "plans", "believes", "seeks",
"estimates",  and variations of such words and similar  expressions are intended
to identify such  forward-looking  information.  Therefore,  actual outcomes and
results may differ  materially  from what is  expressed  or  forecasted  in such
forward-looking  information due to numerous factors, including, but not limited
to, availability of financing for operations, successful performance of internal
operations,  impact of  competition  and other risks  detailed  below as well as
those  discussed  elsewhere  in this  Form  10-QSB  and from time to time in the
Company's  Securities and Exchange  Commission filings and reports. In addition,
general  economic  and market  conditions  and growth  rates  could  affect such
statements.

Liquidity and Capital Resources

Since fiscal 1998 the Company has had to fund substantial  losses as the Company
determined  to cease  sale of  stainless  steel and  develop  the market for its
Nuovinox products.  In fiscal 1999 the Company incurred a loss of $3,150,498 and
in fiscal 2000  incurred a loss of  $2,279,926.  Because  the  Company  incurs a
substantial amount of depreciation and amortization, $506,050 in fiscal 1999 and
$538,673  in  fiscal  2000,  the cash  losses  for  fiscal  1999  and 2000  were
approximately $2,640,000 and $1,740,000, respectively.

In fiscal 1999 the cash loss of approximately  $2,640,000 was principally funded
through the liquidation of current assets. Between March 31, 1998, and March 31,
1999,  the  Company's   cash  position   decreased  from  $852,892  to  $42,973,
receivables  decreased from $597,426 to $19,505 and  inventories  decreased from
$948,093 to $195,663, a reduction in current assets of $2,140,271. The amount of
the cash loss that was not funded  through the  liquidation of current assets as
well as some  increases in property  were funded  through  sales of common stock
that netted $726,670.

In fiscal  2000 the cash loss of  approximately  $1,740,000  was funded  through
financing   activities.   A  related  party  loaned  the  Company  approximately
$1,000,000  and the Company  issued common stock,  the sale of which resulted in
net proceeds to the Company of approximately $800,000.

Total equity at the end of fiscal 1999 was  $8,402,251  and at the end of fiscal
2000 was $6,916,143. At the end of both fiscal 1999 and 2000, the Company had no
long-term debt.

In fiscal  1999 and 2000 the  Company  developed  the  market  for its  Nuovinox
product,  much of which involved extensive testing for United States federal and
state  transportation  authorities  to  demonstrate  the utility of the Nuovinox
product in bridges and  highways.  By the end of fiscal  2000,  this process was
sufficiently  complete  to begin  sales.  With the  Company's  plant  facilities
unencumbered, in July 2000 the Company's United States subsidiary entered into a
Loan and Security Agreement with Banc of America Commercial Finance  Corporation
(the  "Loan  Agreement")  whereby  the  Company  obtained a Term Loan as well as
Revolving  Credit and Credit  Accommodations.  The  maximum  amount  that can be
borrowed under the Loan Agreement is $5,750,000.

The Term Loan  limits the amount that can be  borrowed  pursuant  thereto to the
lesser of $5,000,000 or 80% of the auction sales value of certain equipment,  as
defined, at the Company's Aberneath, South Wales, UK facility.

The  Revolving  Credit and  Credit  Accommodation  provides,  subject to certain
provisions,  that the Company may borrow up to 50% of the value, as defined,  of
the Company's inventory as well as 50% of the amount of certain receivables,  as
defined.  Borrowing for inventory  cannot exceed $750,000 and borrowing  against
receivables cannot exceed $500,000.

The term loan is repaid monthly and is amortized over a 48 month period, bearing
interest at prime rate plus 2.25%.  The  inventory  and accounts  loan mature 36
months after the date of the agreement and bear interest,  payable  monthly,  at
prime rate plus 2.25%.

In connection  with the Loan Agreement the Company  granted a warrant to Bank of
America  Commercial  Finance  Corporation  to purchase  up to 160,000  shares of
common stock.

The  proceeds  from the term  loan  will be used to fund  operational  losses to
extent  necessary to cover the start up period for Nuovinox sales and to finance
inventory  and  receivables  to the extent that the  Company  will need funds in
excess of borrowing under the Term Loan for inventory and receivables.


<PAGE>


Results of Operations

General

The  Company's  results  of  operations  reflect  the  transition  from  dormant
operations to fulfilling a backlog of orders.  Beginning in the third quarter of
the Company's  current  fiscal year,  which ends December 31, 2000,  the Company
anticipates that its sales will start to increase. Recognition of these revenues
can be subject to a variety of  factors,  particular  since most of these  sales
will be to those contracting for sales to governmental agencies. These sales are
subject to funding and the release of funds.  Hence the timing of the release of
these funds for sales could cause significant variation in revenues from quarter
to quarter,  with the variation of these revenues being sharper when the Company
is smaller.  Further,  these  contracts are large with the Company  having a few
large contracts rather than many small contracts.  The effect of large contracts
and any delay or  acceleration  in the funding or delivery under these contracts
could result in significant variations in revenues from period to period.

Six months ended  September 30, 2000 compared to the six months ended  September
30, 1999

The Company incurred a net loss of $1,146,310 for the six months ended September
30, 2000 compared to a net loss of $1,008,439 for the comparable earlier period.
The  Company's  gross loss  decreased  to $162,810 in the six month period ended
September 30, 2000, down more than $100,000 from the $264,795 loss for the first
six months of 1999. Sales,  accordingly,  more than doubled, from $93,443 in the
first six months of the last fiscal  year,  to  $188,993  in the current  fiscal
year. Cost of sales were flat in both periods,  $358,238 in the first six months
of 1999 and  $351,803  for the  first  six  months  of 2000.  Sales of  Nuovinox
products  principally  occurred  in the first  three  months of fiscal 2001 with
sales of  Nuovinox  products in the second  quarter  being delay due to a change
over from dowels to rebar.

Selling general and administrative costs increased by approximately $100,000, to
$816,376 for the six months ended  September  30, 2000 from $716,018 for the six
months  ended  September  30,  1999.  The  Company  had  reduced  the  number of
administrative  employees but the cost saving from this  reduction was more than
offset from  professional  fees that were incurred in the second  quarter of the
current fiscal year.

The Company incurred  interest expense of $185,684 in the fist six months of the
current fiscal year, principally reflecting the Bank of American financing. This
increase is almost  $150,000  more than the  interest  expense  from the earlier
comparable period.


Quarter ended  September  30, 2000  compared to the quarter ended  September 30,
1999.

The  Company  incurred a net loss of  $677,314  in the second  quarter of fiscal
2001compared  to a loss of $547,489 for the same period in the  previous  fiscal
year. Sales were essentially unchanged,  $55,824 in the later period compared to
$49,854 in the earlier  period.  Sales were flat because the Company changed its
production in the second quarter from dowels to rebar.  Cost of sales  decreased
in the later period  primarily  due to a rebate from the electric  utility.  The
decrease  in cost of sales in the second  quarter  of fiscal  2001 was offset by
increased selling,  general and administrative  expenses because of increases in
professional fees.  Selling,  general and administrative  expenses were $368,162
for the three month period ended  September  30, 1999 and were  $502,737 for the
three month period ended September 30, 2000. While increases in selling, general
and  administrative  expenses  were offset by  decreases in costs of goods sold,
interest  expense  of  $163,687  in the later  period  accounts  for most of the
increase in net loss for the  September  30,  2000  period when  compared to the
earlier period.


<PAGE>


Item 3. Quantitative and Qualitative Disclosures About Market Risk.

The  Company  does not engage in any  hedging  activities.  In  particular,  the
Company does not hedge its sales for currency  fluctuations,  and,  accordingly,
does not acquire  market risk  sensitive  instruments.  Over the last two fiscal
years,  market  risks  have  been  negligible  because  of the  small  amount of
operations in which the Company has engaged.

The Company's  primary market risk is anticipated to be a currency exchange rate
risk and the  Company  does not,  at the present  time,  anticipate  engaging in
management of that risk. For the next fiscal year, the Company's operations will
be  principally  conducted in the United  Kingdom with sales  anticipated in the
United States and Canada.  In addition to currency  market risk  resulting  from
trade  accounts  receivable,   the  Company's  loan  with  Bank  of  America  is
denominated in U.S. Dollars. The amounts available to the Company under the Bank
of America  loan  agreement  are  principally  based upon assets  located in the
United Kingdom,  and a large increase in the value of the Dollar relative to the
Pound  could  diminish  the  amounts  that  could be  available  under that loan
agreement.  A  significant  increase in the Pound  relative to Dollar would make
United States trade  receivables  worth less in the United  Kingdom,  decreasing
profit  margins  for  products  produced  in the United  Kingdom and sold in the
United States.


<PAGE>


PART - II

Item 6. Exhibits and Reports on Form 8-K

(a)      Exhibit 27 - Financial Data Schedule


<PAGE>


                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  exchange Act of 1934,
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned.

                                        Stelax Industries, Ltd.


Dated: November 23, 2000                /s/ Harmon S. Hardy
                                        -----------------------------------
                                        Harmon S. Hardy, President and
                                        Principal Financial Officer





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission